Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

1.14.99.29: deoxyhypusine monooxygenase

This is an abbreviated version!
For detailed information about deoxyhypusine monooxygenase, go to the full flat file.

Word Map on EC 1.14.99.29

Reaction

[eIF5A]-deoxyhypusine
+
reduced acceptor
+
O2
=
[eIF5A]-hypusine
+
acceptor
+
H2O

Synonyms

deoxyhypusine hydroxylase, deoxyhypusine hydroxylase homologue nero, deoxyhypusine synthase/hydroxylase, deoxyhypusyl hydroxylase, DOHH, DOOH, hDOHH, Lia1, More, nero, oxygenase, deoxyhypusine di-

ECTree

     1 Oxidoreductases
         1.14 Acting on paired donors, with incorporation or reduction of molecular oxygen
             1.14.99 Miscellaneous
                1.14.99.29 deoxyhypusine monooxygenase

Disease

Disease on EC 1.14.99.29 - deoxyhypusine monooxygenase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Adenocarcinoma
A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.
Glioblastoma
Expression of Eukaryotic Initiation Factor 5A and Hypusine Forming Enzymes in Glioblastoma Patient Samples: Implications for New Targeted Therapies.
Leishmaniasis
Targeting polyamine metabolism for finding new drugs against leishmaniasis: a review.
Malaria
A suggested vital function for eIF-5A and dhs genes during murine malaria blood-stage infection.
Chemical profiling of deoxyhypusine hydroxylase inhibitors for antimalarial therapy.
Deoxyhypusine Hydroxylase from Plasmodium vivax, the Neglected Human Malaria Parasite: Molecular Cloning, Expression and Specific Inhibition by the 5-LOX Inhibitor Zileuton.
Neoplasms
Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.
The polyamine-derived amino acid hypusine: its post-translational formation in eIF-5A and its role in cell proliferation.
Prostatic Neoplasms
Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells.